Balance Sheet Data
Nektar Therapeutics (NKTR)
$0.525
+0.04 (+7.14%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 1,335.35 | 1,324.86 | 1,061.90 | 733.96 | 504.98 | 446.14 | 334.60 | 250.94 | 188.20 | 141.15 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 43.21 | 36.80 | 38.89 | 22.49 | 5.98 | 12.39 | 9.29 | 6.97 | 5.23 | 3.92 |
| Account Receivables (%) | ||||||||||
| Inventories | 11.38 | 12.67 | 15.29 | 15.80 | 19.20 | 8.06 | 6.04 | 4.53 | 3.40 | 2.55 |
| Inventories (%) | ||||||||||
| Accounts Payable | 5.85 | 19.23 | 22.14 | 9.75 | 12.98 | 7.65 | 5.74 | 4.30 | 3.23 | 2.42 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -14.24 | -26.29 | -7.26 | -14.99 | -5.68 | -6.87 | -5.15 | -3.86 | -2.90 | -2.17 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.